Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis-Reference-Cited by-同舟云学术

Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis

Published:2023-03 Issue:3 Volume:78 Page:534-542
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Choi Won-Mook,Yip Terry Cheuk-Fung,Wong Grace Lai-Hung,Kim W. Ray,Yee Leland J.,Brooks-Rooney Craig,Curteis Tristan,Cant Harriet,Chen Chien-Hung,Chen Chi-Yi,Huang Yi-Hsiang,Jin Young-Joo,Jun Dae Won,Kim Jin-Wook,Park Neung Hwa,Peng Cheng-Yuan,Shin Hyun Phil,Shin Jung Woo,Yang Yao-Hsu,Lim Young-Suk

Funder

Gilead Sciences

Publisher

Elsevier BV

Subject

Hepatology

Reference51 articles.

1. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study;Razavi-Shearer;Lancet Gastroenterol Hepatol,2018

2. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

3. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis;Gomaa;World J Gastroenterol,2008

4. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

5. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection;Lampertico;J Hepatol,2017

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RBM12 drives PD-L1-mediated immune evasion in hepatocellular carcinoma by increasing JAK1 mRNA translation;Oncogene;2024-08-26

2. Economic evaluation of hepatocellular carcinoma surveillance in chronic hepatitis B patients with virological remission;BMC Public Health;2024-08-13

3. A systematic review and meta-analysis comparing the impact of tenofovir and entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma patients undergoing liver resection;Frontiers in Pharmacology;2024-07-29

4. Tenofovir Is Associated With a Better Prognosis Than Entecavir for Hepatitis B Virus–Related Hepatocellular Carcinoma;Clinical Gastroenterology and Hepatology;2024-07

5. Current trends and advances in antiviral therapy for chronic hepatitis B;Chinese Medical Journal;2024-06-28